Gene · 5158
Papers1,506
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 1,506
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| cGMP Signaling in Photoreceptor Degeneration. | Int J Mol Sci | 2023 | 37446378 | PubTator, text mining | PubMed |
| Clinical Characteristics and Genetic Variants of a Large Cohort of Patients with Retinitis Pigmentosa Using Multimodal Imaging and Next Generation Sequencing. | Int J Mol Sci | 2023 | 37446072 | PubTator, text mining | PubMed |
| Human Mutations in Arl3, a Small GTPase Involved in Lipidated Cargo Delivery to the Cilia, Cause Retinal Dystrophy. | Adv Exp Med Biol | 2023 | 37440046 | PubTator, text mining | PubMed |
| Cone dystrophy associated with autoimmune polyglandular syndrome type 1. | Sci Rep | 2023 | 37433860 | PubTator, text mining | PubMed |
| Low-Profile Broadband Dual-Polarized Dipole Antenna for Base Station Applications. | Sensors (Basel) | 2023 | 37420814 | PubTator, text mining | PubMed |
| Neuronal p58IPK Protects Retinal Ganglion Cells Independently of Macrophage/Microglia Activation in Ocular Hypertension. | Cells | 2023 | 37371028 | PubTator, text mining | PubMed |
| A New Preclinical Model of Retinitis Pigmentosa Due to Pde6g Deficiency. | Ophthalmol Sci | 2023 | 37363133 | PubTator, text mining | PubMed |
| A Plasmodium membrane receptor platform integrates cues for egress and invasion in blood forms and activation of transmission stages. | Sci Adv | 2023 | 37327340 | PubTator, text mining | PubMed |
| Starburst amacrine cells amplify optogenetic visual restoration through gap junctions. | Mol Ther Methods Clin Dev | 2023 | 37324975 | PubTator, text mining | PubMed |
| Next-generation sequencing--based genetic testing and phenotype correlation in retinitis pigmentosa patients from India. | Indian J Ophthalmol | 2023 | 37322672 | PubTator, text mining | PubMed |
| Identification of hub genes correlated with diabetic retinopathy via bioinformatics methods. | Eur Rev Med Pharmacol Sci | 2023 | 37318461 | PubTator, text mining | PubMed |
| A genotype-to-phenotype approach suggests under-reporting of single nucleotide variants in nephrocystin-1 (NPHP1) related disease (UK 100,000 Genomes Project). | Sci Rep | 2023 | 37296294 | PubTator, text mining | PubMed |
| Genetic causes of inherited retinal diseases among Israeli Jews of Ethiopian ancestry. | Mol Vis | 2023 | 37287645 | PubTator, text mining | PubMed |
| Adeno-Associated Virus (AAV) - Based Gene Therapies for Retinal Diseases: Where are We? | Appl Clin Genet | 2023 | 37274131 | PubTator, text mining | PubMed |
| Natural history of retinitis pigmentosa based on genotype, vitamin A/E supplementation, and an electroretinogram biomarker. | JCI Insight | 2023 | 37261916 | PubTator, text mining | PubMed |
| A clinically viable approach to restoring visual function using optogenetic gene therapy. | Mol Ther Methods Clin Dev | 2023 | 37251979 | PubTator, text mining | PubMed |
| Identification of Rare Variants Involved in High Myopia Unraveled by Whole Genome Sequencing. | Ophthalmol Sci | 2023 | 37250922 | PubTator, text mining | PubMed |
| Inherited Retinal Degeneration: Towards the Development of a Combination Therapy Targeting Histone Deacetylase, Poly (ADP-Ribose) Polymerase, and Calpain. | Biomolecules | 2023 | 37189329 | PubTator, text mining | PubMed |
| Exploring the Therapeutic Potential of Elastase Inhibition in Age-Related Macular Degeneration in Mouse and Human. | Cells | 2023 | 37174708 | PubTator, text mining | PubMed |
| A nonsense mutation in C8orf37 linked with retinitis pigmentosa, early macular degeneration, cataract, and myopia in an arRP family from North India. | BMC Ophthalmol | 2023 | 37170250 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5158/papers?page=7